ArticleBMC primary care2026
The importance of office spirometry in guiding the management of patients with chronic airway disorders in primary care.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectivesOffice spirometry is used for the diagnosis of patients with asthma or chronic obstructive pulmonary disease (COPD). The study aimed to determine the outcomes of post-office spirometry of patients in primary care on their clinical diagnosis, medication treatment and referral for pulmonologist evaluation.
methodsThis retrospective study was conducted in Singapore primary care clinics over two years. Demographic, clinical and prescription data were extracted from the institution electronic medical records of Asian patients 3-month before and 6-month post-spirometry. Spirometry outcomes were: Significant Bronchodilator Responsiveness (SBR); Post Bronchodilator Obstruction (PBO); SBR and PBO; and unconfirmed diagnosis.
resultsSpirometry outcomes of 343 patients were analysed. Among 151 (44.0%) with an initial diagnosis of asthma, 19 (12.6%) had SBR, which confirmed the asthma diagnosis, 9.3% had both SBR and PBO. Among 45 (13.1%) with an initial diagnosis of COPD, 10 (22.2%) had PBO which confirmed the COPD diagnosis, and 4.4% of patients had both SBR and PBO. 85 patients (24.8%) were referred to pulmonologist for further evaluation, with the highest referral rate observed in patients with SBR + PBO (33.3%).
conclusionSpirometry is essential to affirm diagnosis of patients with COPD in primary care. Majority of patients with an asthma diagnosis did not demonstrate positive SBR, and further evaluations might be required. Spirometry should be scaled to ensure that patients receive the appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.